Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hamer

Showing results (281-290 of 748) with videos related to

Pageof 75
Sort By:
Epilepsy & Behavior : E&B|January 13, 2010
Localizing and lateralizing value of ictal flatulenceAdam Strzelczyk, Mareike Nowak, Sebastian Bauer, et al.
Clinical Genetics|September 4, 1998
Association of long variants of the dopamine D4 receptor exon 3 repeat polymorphism with Parkinson's diseaseM H Ricketts, R M Hamer, P Manowitz, et al.
The Clinical Journal of Pain|November 28, 2013
Cathodal and anodal left prefrontal tDCS and the perception of control over painJennifer C Naylor, Jeffery J Borckardt, Christine E Marx, et al.
European Neurology|June 17, 2021
Pre- and Postictal Changes in the Innate Immune System: Cause or Effect?Johannes D Lang, David G Olmes, Manuel Proske, et al.
Neurocritical Care|March 19, 2014
Seizures among long-term survivors of conservatively treated ICH patients: incidence, risk factors, and impact on functional outcomeDominik Madžar, Joji B Kuramatsu, Stephanie Gollwitzer, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 18, 2003
Atypical and conventional antipsychotic drugs in treatment-naive first-episode schizophrenia: a 52-week randomized trial of clozapine vs chlorpromazineJeffrey A Lieberman, Michael Phillips, Hongbin Gu, et al.
Schizophrenia Research|January 18, 2017
A 12-week randomized controlled trial of twice-daily intranasal oxytocin for social cognitive deficits in people with schizophreniaL Fredrik Jarskog, Cort A Pedersen, Jacqueline L Johnson, et al.
Schizophrenia Research|April 6, 2004
First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidolAlan I Green, Mauricio F Tohen, Robert M Hamer, et al.
Epilepsy & Behavior : E&B|January 23, 2010
Memory for public events in patients with unilateral temporal lobe epilepsyAnja Haag, Sonja Barth, Maja Zibelius, et al.
JAMA|November 8, 1985
Posttraumatic stress disorder from pentaborane intoxication. Neuropsychiatric evaluation and short-term follow-upJ J Silverman, R P Hart, L K Garrettson, et al.
Pageof 75

Showing results (281-290 of 748) with videos related to

Sort By:
Pageof 75
Epilepsy & Behavior : E&B|January 13, 2010
Localizing and lateralizing value of ictal flatulenceAdam Strzelczyk, Mareike Nowak, Sebastian Bauer, et al.
Clinical Genetics|September 4, 1998
Association of long variants of the dopamine D4 receptor exon 3 repeat polymorphism with Parkinson's diseaseM H Ricketts, R M Hamer, P Manowitz, et al.
The Clinical Journal of Pain|November 28, 2013
Cathodal and anodal left prefrontal tDCS and the perception of control over painJennifer C Naylor, Jeffery J Borckardt, Christine E Marx, et al.
European Neurology|June 17, 2021
Pre- and Postictal Changes in the Innate Immune System: Cause or Effect?Johannes D Lang, David G Olmes, Manuel Proske, et al.
Neurocritical Care|March 19, 2014
Seizures among long-term survivors of conservatively treated ICH patients: incidence, risk factors, and impact on functional outcomeDominik Madžar, Joji B Kuramatsu, Stephanie Gollwitzer, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 18, 2003
Atypical and conventional antipsychotic drugs in treatment-naive first-episode schizophrenia: a 52-week randomized trial of clozapine vs chlorpromazineJeffrey A Lieberman, Michael Phillips, Hongbin Gu, et al.
Schizophrenia Research|January 18, 2017
A 12-week randomized controlled trial of twice-daily intranasal oxytocin for social cognitive deficits in people with schizophreniaL Fredrik Jarskog, Cort A Pedersen, Jacqueline L Johnson, et al.
Schizophrenia Research|April 6, 2004
First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidolAlan I Green, Mauricio F Tohen, Robert M Hamer, et al.
Epilepsy & Behavior : E&B|January 23, 2010
Memory for public events in patients with unilateral temporal lobe epilepsyAnja Haag, Sonja Barth, Maja Zibelius, et al.
JAMA|November 8, 1985
Posttraumatic stress disorder from pentaborane intoxication. Neuropsychiatric evaluation and short-term follow-upJ J Silverman, R P Hart, L K Garrettson, et al.
Pageof 75